Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human KCNIP4 ELISA Kit (AC2423)
Cat.#: ASET-1012
Specifications
Description Human KCNIP4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNIP4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.024 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.25-20 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1712 Human GnRHR ELISA Kit (AC3123) Quantitative inquiry ASET-1820 Human MC4-R ELISA Kit (AC3231) Quantitative inquiry ASET-2095 Rat Dopamine D2 Receptor ELISA Kit (AC3506) Quantitative inquiry ASET-1492 Human GABARAPL1 ELISA Kit (AC2903) Quantitative inquiry ASET-1001 Human Apo-D ELISA Kit (AC2412) Quantitative inquiry ASET-1277 Rat BACE2 ELISA Kit (AC2688) Quantitative inquiry ASET-1566 Rabbit Luteinizing Hormone ELISA Kit (AC2977) Quantitative inquiry ASET-1570 Human Neurotrophin 3 ELISA Kit (AC2981) Quantitative inquiry ASET-2313 Human Neuropeptide Y ELISA Kit (AC3724) Quantitative inquiry ASET-1390 Mouse Clathrin Light Chain ELISA Kit (AC2801) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket